QA: Axsome Therapeutics Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2019_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001579428')"}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc.

  xvar xval
0 AssetsCurrent 15,215,102
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 51,832
3 remainder_Assets 112,345
4 LiabilitiesCurrent 10,821,938
5 LiabilitiesNoncurrent 3,619,420
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,351,522
9 ResearchAndDevelopmentExpense 23,495,055
10 remainder_Expenses -2,791,000
11 remainder_Revenues 0
12 remainder_NetIncome -909,887
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,379,279
1 Liabilities 14,441,358
2 Expenses 30,055,577
3 Revenues 0
4 StockholdersEquity 937,921
5 NetIncome -30,965,464
6 ComprehensiveNetIncome -30,965,464
7 BaseVar 30,393,050
8 EconomicCapitalRatio -1.97

Edgar->Model Mapping

Feature Distribution

Change over Time